Dr. Art Mollen: Dangers of Avandia

Posted: Updated:

PHOENIX -- News this week about the dangers of Avandia -- a controversial diabetes drug -- made a splash in the The New York Times and caused Glaxo-Smith-Klein stock to drop.

Is this report anything new? Dr. Art Mollen says, "No," but it's being brought to the forefront again by two senators.